![Keith D. Terry](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Keith D. Terry
Geen lopende functies
Loopbaan van Keith D. Terry
Eerdere bekende functies van Keith D. Terry
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PathoGenesis Corp
![]() PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Corporate Officer/Principal | - | - |
OcuSub, Inc.
![]() OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Oprichter | 01-03-2002 | - |
Corporate Officer/Principal | 04-11-2009 | - |
Opleiding van Keith D. Terry
University of Wisconsin | Undergraduate Degree |
The University of Chicago | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Corporate Officer/Principal | 2 |
Founder | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
OcuSub, Inc.
![]() OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Health Technology |
PathoGenesis Corp
![]() PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
- Beurs
- Insiders
- Keith D. Terry
- Ervaring